Trial Profile
Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Patients With Schizophrenia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- 02 Feb 2024 Planned End Date changed from 1 Dec 2023 to 1 Jun 2024.
- 02 Feb 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Jun 2024.
- 30 Mar 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.